Peripheral inflammatory markers in amnestic mild cognitive impairment

International Journal of Geriatric Psychiatry

Volumn 29, Issue 3, 2014, Pages 221-226

  Karim, Salman ^a   Hopkins, Steve ^b   Purandare, Nitin ^c   Crowther, Jackie ^d   Morris, Julie ^e   Tyrrell, Pippa ^a   Burns, Alistair ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

CRP; IL6; inflammatory markers; mild cognitive impairment

Indexed keywords

CRP; IL6; INFLAMMATORY MARKERS; MILD COGNITIVE IMPAIRMENT;

AGED; AMNESIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ENGLAND; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 84893961105     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3988     Document Type: Article

References (40)

1. Alley DE, Crimmins EM, Karlamangla A, Hu P, Seeman TE,. 2008. Inflammation and rate of cognitive change in high-functioning older adults. J Gerontol Series A, Biol Sci Med Sci 63: 50-55.
2. Axelrod B, Millis S,. 1994. Preliminary Standardization of the Cognitive Estimation Test. Assessment 1: 269-274.
3. Banati RB,. 2002. Visualising microglial activation in vivo. Glia 40: 206-217.
4. Bermejo P, Martín-Aragõn S, Benedí J, et al,. 2008. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. Immunol Lett 117: 198-202.
5. Blair JR, Spreen O, 1989. Predicting premorbid IQ: A revision of the national adult reading test. Clin Neuropsychol 3: 129-136.
6. Cuello AC,. 2011. Pro-Inflammatory Processes in the Alzheimer's Pathology. Curr Alzheimer Res 8 (2). Editorial.
7. De Craen Ajm, Gussekloo J, Vrijsen B, Westendorp Rgj,. 2005. Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia. Am J Epidemiol 161: 114-120.
8. Dik MG, Jonker C, Hack CE, et al,. 2005. Serum inflammatory proteins and cognitive decline in older persons. Neurology 64: 1371-1377.
9. Duthie A, Chew D, Soiza RL,. 2011. Non-psychiatric comorbidity associated with Alzheimer's disease. QJM 104 (11): 913-920.
10. Edison P, Archer HA, Gerhard A, et al,. 2008. Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32: 412-419.
11. Eikelenboom P, Hoogendijk Wjg, Jonker C, Van Tilburg W,. 2002. Immunological mechanisms and the spectrum of psychiatric syndromes in Alzheimer's disease. J Psychiatr Res 36: 269-280.
12. Eiriksdottir G, Aspelund T, Bjarnadottir K, et al,. 2006. Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik study. Atherosclerosis 186: 222-224.
13. Folstein M, Folstein SE, McHugh PR,. 1975. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
14. Godbout JP, Johnson RW,. 2004 Interleukin-6 in the aging brain. J Neuroimmunol 47: 141-144.
15. Grober E, Buschke H,. 1987. Genuine memory deficits in dementia. Dev Neuropsychol 3: 13-36.
16. Guerreiro RJ, Santana I, Brás JM, et al,. 2007. Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment. Neurodegener Dis 4: 406-412.
17. Irwin MR, Miller AH, 2007. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21: 374-383.
18. Laurin D, David CJ, Masaki KH, White LR, Launer LJ,. 2009. Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up. Neurobiol Aging 30 (11): 1724-1727.
19. Magaki S, Mueller C, Dickson C, Kirsch W,. 2007. Increased production of inflammatory cytokines in mild cognitive impairment. Exp Gerontol 42: 233-240.
20. Mattson MP,. 2004. Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 3: 105-120.
21. McGeer PL, McGeer EG,. 2007. NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 28: 639-647.
22. Moore AH, O'Banion MK,. 2002. Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease. Adv Drug Deliv Rev 54: 1627-1656.
23. Okello A, Edison P, Archer HA, et al,. 2009. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology, 72, 56-62.
24. Oztürk C, Ozge A, Yalin OO, et al,. 2007. The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: correlation with cognitive and functional decline. Behav Neurol, 18, 207-215.
25. Petersen RC,. 2011. Mild Cognitive Impairment. N Engl J Med 364: 2227-2234.
26. Petersen RC, Parisi JE, Dickson DW, et al,. 2006. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 63 (5): 665-672.
27. Petersen RC, Thomas RG, Grundman M, et al,. 2005. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med, 352, 2379-2388.
28. Raison CL, Capuron L, Miller AH,. 2006. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27: 24-31.
29. Roberts RO, Geda YE, Knopman DS, et al,. 2009. Association of C-reactive protein with mild cognitive impairment. Alzheimer's Dement J Alzheimer's Assoc 5: 398-405.
30. Roth M, Huppert FA, Mountjoy CQ, Tym E,. 1999. The Cambridge Examination for Mental Disorders of the Elderly-Revised. Cambridge University Press: Cambridge.
31. Schuitemaker A, Dik MG, Veerhuis R, et al,. 2009. Inflammatory markers in AD and MCI patients with different biomarker profiles. Neurobiol Aging 30: 1885-1889.
32. Spreen O, Strauss E,. 1998. A Compendium of Neuropsychological Tests (2nd edn). Oxford University Press: New York.
33. Steinman L,. 2008. Nuanced roles of cytokines in three major human brain disorders. J Clin Invest 118 (11): 3557-3563.
34. Tan ZS, Seshadri S,. 2010. Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander? Alzheimer's Res Therapy 2: 6.
35. Tan ZS, Beiser AS, Vasan RS, et al,. 2007. Inflammatory markers and the risk of Alzheimer disease: the Framingham study. Neurology 68: 1902-1908.
36. Vlad SC, Miller DR, Kowall NW, Felson DT,. 2008. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70: 1672-1677.
37. Weuve J, Ridker PM, Cook NR, Buring JE, Grodstein F,. 2006. High-sensitivity C-reactive protein and cognitive function in older women. Epidemiol (Cambridge, Mass) 17: 183-189.
38. Wyss-Coray T,. 2005. Killing pain, killing neurons? Nat Med 11: 472-473.
39. Yaffe K, Lindquist K, Penninx BW, et al,. 2003. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61: 76-80.
40. Zhao SJ, Guo CN, Wang MQ, Chen WJ, Zhao YB,. 2012. Serum levels of inflammation factors and cognitive performance in amnestic mild cognitive impairment: a Chinese clinical study. Cytokine 57 (2): 221-225.